544 related articles for article (PubMed ID: 9070312)
21. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
[TBL] [Abstract][Full Text] [Related]
23. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells.
Michaëlsson E; Broddefalk J; Engström A; Kihlberg J; Holmdahl R
Eur J Immunol; 1996 Aug; 26(8):1906-10. PubMed ID: 8765038
[TBL] [Abstract][Full Text] [Related]
24. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness.
Cruz PD; Bergstresser PR
Dermatol Clin; 1990 Oct; 8(4):633-47. PubMed ID: 1979019
[TBL] [Abstract][Full Text] [Related]
25. Freshly isolated mouse 4F7+ splenic dendritic cells process and present exogenous antigens to T cells.
Mohamadzadeh M; Pavlidou A; Enk A; Knop J; Rüde E; Gradehandt G
Eur J Immunol; 1994 Dec; 24(12):3170-4. PubMed ID: 7805745
[TBL] [Abstract][Full Text] [Related]
26. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
St-Pierre Y; Watts TH
J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
[TBL] [Abstract][Full Text] [Related]
27. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
Svensson M; Stockinger B; Wick MJ
J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
[TBL] [Abstract][Full Text] [Related]
29. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
[TBL] [Abstract][Full Text] [Related]
30. Short-term administration of ethanol in mice deviates antigen presentation activity towards B cells.
Andrade MC; Albernaz MJ; Araújo MS; Santos BP; Teixeira-Carvalho A; Faria AM; Martins-Filho OA
Scand J Immunol; 2009 Sep; 70(3):226-37. PubMed ID: 19703012
[TBL] [Abstract][Full Text] [Related]
31. Functional heterogeneity of culture-grown bone marrow-derived macrophages. II. Lymphokine stimulation of antigen-presenting function.
Lee KC; Wong M
J Immunol; 1982 Jun; 128(6):2487-92. PubMed ID: 6978905
[TBL] [Abstract][Full Text] [Related]
32. B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway.
Clark MR; Massenburg D; Siemasko K; Hou P; Zhang M
Curr Opin Immunol; 2004 Jun; 16(3):382-7. PubMed ID: 15134789
[TBL] [Abstract][Full Text] [Related]
33. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
[TBL] [Abstract][Full Text] [Related]
34. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes.
Stockinger B
Eur J Immunol; 1992 May; 22(5):1271-8. PubMed ID: 1577067
[TBL] [Abstract][Full Text] [Related]
35. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
36. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
37. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
[TBL] [Abstract][Full Text] [Related]
38. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
39. Endosomal sorting of MHC class II determines antigen presentation by dendritic cells.
van Niel G; Wubbolts R; Stoorvogel W
Curr Opin Cell Biol; 2008 Aug; 20(4):437-44. PubMed ID: 18582577
[TBL] [Abstract][Full Text] [Related]
40. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation.
Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK
Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
